Volunteer Donate Get Help

Precision Medicine For Children

Published: 2020-05-01 |

Source: Leukemia & Lymphoma Society

As part of The LLS Children's Initiative, LLS is working with a team of renowned pediatric oncologists to lay the groundwork for a global precision medicine master clinical trial to match children with relapsed acute leukemia to a targeted therapy based on the specific abnormalities driving their cancer.

The goal of the LLS PedAL master clinical trial is to test multiple targeted therapies simultaneously at up to 200 clinical sites worldwide, LLS anticipates treating the first patient in the spring or summer of 2020.

In addition to the clinical trial, LLS seeks to break down silos that prevent researchers from sharing data about pediatric cancer data from multiple institutions into a single data set, establish a common language to define and analyze the data and make that data available to researchers worldwide.

Gwen Nichols, MD, Chief Medical Officer of The Leukemia & Lymphoma Society, heads a team of preeminent leaders in pediatric acute leukemia to conceive, develop and implement LLS PedAL.

©2015 Stephanie Robinson Foundation | Privacy Policy